EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Small molecule– and peptide–drug conjugates addressing integrins: A story of targeted cancer treatment

Jannik Paulus, Norbert Sewald iD

Journal of Peptide Science · 2024-07 · 30 (7)

DOI: 10.1002/psc.3561 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Peptide Science, online erschienen am 21.02.2024. Verfasst von Jannik Paulus und 1 weiteren Autor:innen. Beteiligte Einrichtung: Organic and Bioorganic Chemistry, Faculty of Chemistry, Bielefeld University, Bielefeld, Germany. Hauptthemen laut MEDLINE: Neoplasms, Peptides, Antineoplastic Agents, Integrins. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 457 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted cancer treatment should avoid side effects and damage to healthy cells commonly encountered during traditional chemotherapy. By combining small molecule or peptidic ligands as homing devices with cytotoxic drugs connected by a cleavable or non‐cleavable linker in peptide–drug conjugates (PDCs) or small molecule–drug conjugates (SMDCs), cancer cells and tumours can be selectively targeted. The development of highly affine, selective peptides and small molecules in recent years has allowed PDCs and SMDCs to increasingly compete with antibody‐drug conjugates (ADCs). Integrins represent an excellent target for conjugates because they are overexpressed by most cancer cells and because of the broad knowledge about native binding partners as well as the multitude of small‐molecule and peptidic ligands that have been developed over the last 30 years. In particular, integrin α V β 3 has been addressed using a variety of different PDCs and SMDCs over the last two decades, following various strategies. This review summarises and describes integrin‐addressing PDCs and SMDCs while highlighting points of great interest.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsPeptidesAntineoplastic AgentsIntegrinsHumansImmunoconjugatesSmall Molecule LibrariesLigandsAnimals

Stichwörter der Autor:innen

drug conjugatesintegrinspeptidespeptidomimeticstumor targeting

Substanzen

PeptidesAntineoplastic AgentsIntegrinsImmunoconjugatesSmall Molecule LibrariesLigands

Autor:innen und Institutionen

  • Organic and Bioorganic Chemistry, Faculty of Chemistry, Bielefeld University, Bielefeld, Germany.

ORCID-Profile: Norbert Sewald

Zitieren

APA

Paulus, J., & Sewald, N. (2024). Small molecule– and peptide–drug conjugates addressing integrins: A story of targeted cancer treatment. Journal of Peptide Science, 30(7). https://doi.org/10.1002/psc.3561

Vancouver

Paulus J, Sewald N. Small molecule– and peptide–drug conjugates addressing integrins: A story of targeted cancer treatment. Journal of Peptide Science. 2024;30(7). doi:10.1002/psc.3561

BibTeX
@article{Paulus2024,
  author = {Paulus, Jannik and Sewald, Norbert},
  title = {Small molecule– and peptide–drug conjugates addressing integrins: A story of targeted cancer treatment},
  journal = {Journal of Peptide Science},
  year = {2024},
  volume = {30},
  number = {7},
  doi = {10.1002/psc.3561}
}
Kostenlos starten →